Also trades as: IPD.AX (ASX) · $vol 0M
IPDQF OTC
ImpediMed Limited
1W: -18.2%
1M: -15.9%
3M: -18.2%
YTD: -81.8%
1Y: -83.3%
3Y: -95.9%
5Y: -94.9%
$0.00
-0.00 (-18.18%)
Weekly Expected Move ±22.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$15M
+14.7% ▲
5Y CAGR: +11.8%
Gross Profit
-$12M
-208.2% ▼
Operating Income
-$22M
+8.9% ▲
Net Income
-$25M
-7.0% ▼
EPS (Diluted)
$-0.01
-1.7% ▼
EBITDA
-$22M
-25.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $10M | $11M | $10M | $13M | $15M |
| YoY Growth | +25.6% | +8.1% | -11.4% | +26.6% | +14.7% |
| Cost of Revenue | $2M | $25M | $1M | $2M | $26M |
| Gross Profit | $9M | -$14M | $9M | $11M | -$12M |
| Gross Margin | 83.7% | -120.4% | 86.9% | 86.3% | -81.4% |
| R&D Expenses | $683K | $598K | $221K | $0 | $0 |
| SG&A Expenses | $19M | $20M | $23M | $22M | $10M |
| Operating Expenses | $30M | $9M | $33M | $35M | $10M |
| Operating Income | -$22M | -$23M | -$24M | -$24M | -$22M |
| Operating Margin | -205.2% | -201.4% | -241.8% | -190.4% | -151.3% |
| Interest Expense | $28K | $34K | $93K | $1M | $4M |
| Income Before Tax | -$20M | -$22M | -$20M | -$23M | -$26M |
| Tax Expense | $46K | -$2M | $33K | $26K | -$1M |
| Net Income | -$20M | -$21M | -$20M | -$23M | -$25M |
| Net Margin | -189.4% | -180.9% | -196.9% | -182.6% | -170.4% |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$19M | -$20M | -$22M | -$18M | -$22M |
| Shares Outstanding | 1.68B | 1.80B | 2.02B | 2.02B | 2.13B |